Bal Pharma

95.91

-0.51 (-0.53%) tick

NSE

Buy Sell

NSE BSE

Last updated on 7 May 2025 04:53 PM

Open Demat account

Returns

-7.25%

Loading chart...

Fundamentals

Large Cap

Financial - Banking

Market Cap (Cr)

154.83

Earning Per Share

6.5

Dividend Yield

1.31%

P/E Ratio

14.04

P/B Ratio

1.45

Debt to Equity

1.28

Performance

min-value

max-value

Open

56,601.30

52-wk High

75,250.00

High

56,601.30

52-wk Low

75,250.00

Low

56,601.30

Band

75,250.00

Lower Circuit

56,601.30

Upper Circuit

75,250.00

Volume

56,601.30

VWAP

75,250.00

52 Week Performance

min-value

max-value

5.34% down side

up side5.34%

About the company

Bal Pharma Ltd (BPL), a member of the Mcro Laboratories Group, was incorporated as a private limited company in May '87. In Mar.'90, BPL took over a pharmaceutical products manufacturing unit located in Bangalore through the Karnataka State Finance Corporation for a consideration of Rs 25.18 lac following which, BPL commenced manufacturing formulations. BPL manufactures and markets pharmaceutical formulations -- paracetamol, aluminium hydroxide, povidone iodine, alprazolam, gliclazide, griseofulvin, lactobacillus, rifampicin, piroxicam amoxycillin, etc. The company promotes its products through the common sales force of the group but proposes to induct its own soon. It came out with a public issue in Feb.'95 for manufacture of bulk drugs and expansion of pharmaceutical formulations.

Similar Companies

Laurus Labs

610.7 -1.90 (-0.00%) tick

1Yr Returns

+42.64%

Suven Pharmaceuticals

1081.7 -38.10 (-0.03%) tick

1Yr Returns

+68.13%

Piramal Pharma Limited

213.64 +6.92 (0.03%) tick

1Yr Returns

+37.81%

J.B.Chemicals & Pharma

1536.8 +32.40 (0.02%) tick

1Yr Returns

-16.54%

Wockhardt

1251.6 +20.90 (0.02%) tick

1Yr Returns

+127.94%